SecBot SecBot
10-K/A ·Filed Apr 6, 2026

AIRS

Airsculpt Technologies, Inc.
BEARISH
Impact 7/10
Horizonweeks Processed6mo ago SEC0001870940-26-000021
Amended annual report (potential restatement)
Actionable Insight ▼ Bearish

Traders should be concerned about the material weakness in internal controls and the revenue decline. The company's ability to maintain accurate financial reporting is in question, which could lead to further restatements. The 15.8% revenue decline suggests ongoing business challenges despite cost-cutting measures.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
AIRS ▲ +42.26% at T+60d
SHORT call ✗ call lost -42.26% · α vs SPY -28.79% · entry $3.10 → $4.41
Entry = T+0 close
Apr 6, 2026
via day close
T+1d
-5.16%
call +5.16% · α +5.22%
$2.94
settled 7mo ago
T+5d
-13.23%
call +13.23% · α +17.36%
$2.69
settled 7mo ago
T+20d
+10.97%
call -10.97% · α -1.98%
$3.44
settled 6mo ago
T+60d
+42.26%
call -42.26% · α -28.79%
$4.41
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Airsculpt Technologies filed an amended 10-K to correct non-GAAP financial measures, overstating Adjusted EBITDA and Adjusted Net Loss by $2.7 million due to an error related to the London facility closure. The error did not affect GAAP financial statements or audit opinion. The company also disclosed a material weakness in internal controls over lease accounting, which required revision of prior period financials.

Key Facts

  • Amended 10-K corrects $2.7 million overstatement in non-GAAP Adjusted EBITDA and Adjusted Net Loss due to London facility closure accounting error
  • Error did not impact GAAP financial statements or audit opinion
  • Company identified material weakness in internal controls over lease accounting, requiring revision of prior period financials
  • London facility closure resulted in $2.2 million in costs, including $2.4 million loss on PPE and $3.3 million in accelerated rent amortization
  • Company generated $151.8 million revenue in 2025, down 15.8% from $180.4 million in 2024

Financial Impact

Adjusted EBITDA and Adjusted Net Loss overstated by $2.7 million; $2.2 million in costs from London facility closure

Adjusted EBITDAAdjusted Net LossLease accountingRevenue

Risk Factors

  • Material weakness in internal controls over financial reporting
  • Revenue decline of 15.8% year-over-year
  • Potential for further financial restatements
  • Loss of investor confidence due to accounting errors

Market Snapshot

Exchange
Nasdaq
Sector
Services-Offices & Clinics of Doctors of Medicine

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
10-K/A Filing (Primary)0001870940-26-000021
Exhibit: ex231-consentofindependent.htm0001870940-26-000021
Document: a10-kexhibit31212312025.htm0001870940-26-000021
Document: a10-kexhibit31112312025.htm0001870940-26-000021
Document: a10-kexhibit32112312025.htm0001870940-26-000021
Document: 0001870940-26-000021-index-headers.html0001870940-26-000021
Document: 0001870940-26-000021-index.html0001870940-26-000021
Document: 0001870940-26-000021.txt0001870940-26-000021
11 reports for AIRS
Performance horizon
67% Hit rate @ T+20 4 of 6 directional calls Went positive at some point 5 of 6 best @ T+5▲ +16.72%Apr 2, 2026
Filters
Rows
Reports for AIRS — sortable, filterable
TypeNow
Aug 15, 2026
10w ago
Institutional Cluster
NEUTRAL ★ 5/10
$3.09 $2.13▼ −30.96%▼ −28.98%$1.27 (−58.83%)
Aug 10, 2026
11w ago
8-K
BEARISH ★ 7/10
$2.75 $2.71▲ +1.64%▲ +0.72%$1.27 (+53.82%)
Aug 10, 2026
11w ago
Press Release
BEARISH ★ 6/10
$2.75 $2.71▲ +1.64%▲ +0.72%$1.27 (+53.82%)
May 8, 2026
24w ago
8-K
NEUTRAL ★ 4/10
$3.86 $5.11▲ +32.38%▲ +32.36%$1.27 (−67.10%)
May 8, 2026
24w ago
Press Release
BEARISH ★ 6/10
$3.86 $5.11▼ −32.38%▼ −32.36%$1.27 (+67.10%)
May 1, 2026
25w ago
Press Release
NEUTRAL ★ 1/10
$3.32 $5.30▲ +59.64%▲ +54.35%$1.27 (−61.75%)
Apr 6, 2026
29w ago
10-K/A
BEARISH ★ 7/10
$3.10 $3.44▼ −10.97%▼ −1.98%$1.27 (+59.03%)
Apr 6, 2026
29w ago
Press Release
BEARISH ★ 7/10
$3.10 $3.44▼ −10.97%▼ −1.98%$1.27 (+59.03%)
Apr 2, 2026
29w ago
8-K
BEARISH ★ 7/10
$3.17 $2.68▲ +15.46%▲ +25.33%$1.27 (+59.94%)
Apr 2, 2026
29w ago
Press Release
BEARISH ★ 7/10
$3.17 $2.68▲ +15.46%▲ +25.33%$1.27 (+59.94%)
Showing 10 of 11

US Market Status

Market Closed — Opens Thu (10h 19m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 6, 2026